The Insight Partners published latest research report on “Gastric Cancer Diagnostic Procedure Market Size Report, Share, Growth, Trends and Revenue Forecast to 2028 - COVID-19 Impact and Global Analysis By Healthcare Provider, Procedure, Offering, and Disease Indication” the global market size is expected to register a CAGR of 6.5% from 2022 to 2028, it is estimated to grow from USD 1.30 billion in 2022 to USD 1.91 billion by 2028.
The Insight Partners published latest research report on “Gastric Cancer Diagnostic Procedure Market Size Report, Share, Growth, Trends and Revenue Forecast to 2028 - COVID-19 Impact and Global Analysis By Healthcare Provider, Procedure, Offering, and Disease Indication” the global market size is expected to register a CAGR of 6.5% from 2022 to 2028, it is estimated to grow from USD 1.30 billion in 2022 to USD 1.91 billion by 2028.
Download PDF Brochure: https://www.theinsightpartners.com/sample/TIPRE00029842
Global Gastric Cancer Diagnostic Procedure Market Growth Drivers:
• Rising incidence of gastric cancer: The increasing incidence of gastric cancer is one of the key factors driving the growth of the diagnostic procedure market. According to the World Health Organization, gastric cancer is the fifth most common cancer worldwide, with over 1 million new cases diagnosed each year.
• Advancements in diagnostic technologies: The development of advanced diagnostic technologies such as endoscopy, CT scans, and MRI scans is another important driver of market growth. These technologies enable earlier detection and more accurate diagnosis of gastric cancer.
• Growing awareness about cancer screening: Increased awareness about the importance of cancer screening is also driving the growth of the gastric cancer diagnostic procedure market. Governments and healthcare organizations are promoting screening programs to detect cancer at an early stage, which is likely to boost market growth in the coming years.
• Rising healthcare expenditure: The increasing healthcare expenditure across the globe is driving the growth of the gastric cancer diagnostic procedure market. Governments and private organizations are investing in the development of new diagnostic technologies and screening programs, which is likely to boost market growth in the coming years.
• Aging population: The aging population is also contributing to the growth of the gastric cancer diagnostic procedure market. Older individuals are more likely to develop gastric cancer, and are therefore in need of regular screening and diagnostic procedures.
Global Gastric Cancer Diagnostic Procedure Market Analysis - Recent Developments:
• Liquid Biopsy: Liquid biopsy is a non-invasive diagnostic tool that detects circulating tumor cells and tumor DNA in the blood. In 2020, a study was published showing the potential of liquid biopsy for the early detection of gastric cancer. This technology is expected to become more widely used in the coming years.
• AI-Based Diagnostic Tools: Artificial intelligence (AI) is being used to develop more accurate diagnostic tools for gastric cancer. In 2021, Fujifilm Medical Systems USA received FDA clearance for its AI-based endoscopy diagnostic tool, REiLI, which is designed to assist in the detection of gastric cancer.
• New Product Launches: Several new products for the diagnosis of gastric cancer have been launched recently, including Fujifilm’s Endoscopically Guided Ultrasonography (EGUS) system, which combines endoscopy and ultrasound to enable more accurate diagnosis of early-stage gastric cancer.
• Partnerships and Collaborations: Partnerships between healthcare organizations, research institutions, and pharmaceutical companies are becoming more common in the field of gastric cancer diagnosis. In 2021, the National Cancer Center Japan partnered with pharmaceutical company Eisai to develop a liquid biopsy diagnostic test for gastric cancer.
• Regulatory Changes: The regulatory environment for gastric cancer diagnostic procedures is evolving, with new guidelines and regulations being implemented. In 2020, the American Society for Gastrointestinal Endoscopy (ASGE) released new guidelines for endoscopic surveillance of gastric neoplasms, which are likely to impact the use of diagnostic procedures in clinical practice.
Quickly Purchase Premium Copy of Gastric Cancer Diagnostic Procedure Market Growth Report (2022-2028) at: https://www.theinsightpartners.com/buy/TIPRE00029842
Global Gastric Cancer Diagnostic Procedure Market Share Report, Segmentations, Regional & Country Scope:
| Report Coverage | Details |
| Market Size Value in | USD 1.30 Billion in 2022 |
| Market Size Value by | USD 1.91 Billion by 2028 |
| Growth rate | CAGR of 6.5% from 2022 to 2028 |
| Forecast Period | 2022-2028 |
| Base Year | 2022 |
| No. of Pages | 398 |
| No. of Tables | 408 |
| No. of Charts & Figures | 96 |
| Historical data available | Yes |
| Segments covered | Healthcare Provider, Symptom Type, Body Fluid, Procedure, Offering, and Disease Indication |
| Regional scope | North America; Europe; Asia Pacific; Latin America; MEA |
| Country scope | US, UK, Canada, Germany, France, Italy, Australia, Russia, China, Japan, South Korea, Saudi Arabia, Brazil, Argentina |
| Report coverage | Revenue forecast, company ranking, competitive landscape, growth factors, and trends |
| Companies Covered | Atlas-Link Biotech Co Ltd, Bio-Rad Laboratories Inc, MiRXES Pte Ltd, Agilent Technologies Inc, F. Hoffmann-La Roche Ltd, bioMerieux SA, Thermo Fisher Scientific Inc, Illumina Inc, Vela Diagnostics Holding Pte Ltd, Myraid Genetics Inc |
| Key Research Capabilities | Global Market Assessment, Business Development Strategies, Competitive Landscape, Opportunity Analysis, Regional and Country Level Market Analysis, Market Entry Strategies, Market Dynamics, Risk and Return Assessments, Pricing Analysis, Market Size and Forecasting, Company Profiling, Value Chain Analysis, Expansion Strategies, SWOT Analysis, New Product Development |
Browse key market insights spread across 398 pages with 408 list of tables & 96 list of figures from the report, “Gastric Cancer Diagnostic Procedure Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Healthcare Provider (Diagnostic Laboratories, Hospitals, Cancer Research Institutes, Oncology Specialty Clinics, and Others), Symptom Type (Symptomatic and Asymptomatic), Body Fluid (Blood, Urine, Saliva, Stomach Wash/Gastric Juice, Tissue, and Others), Procedure (Endoscopic Procedures, Biopsy & Tissue Tests, Lab Tests, In-Vitro Diagnostic Tests, Imaging Tests, Molecular Diagnostics, Multiplexing Molecular Diagnostics & Immunoassays, and Others), Offering [Instruments, Reagents & Consumables (Including Kits), and Services], and Disease Indication (Early Gastric Cancer and Gastric Cancer Advanced Types)” in detail along with the table of contents: https://www.theinsightpartners.com/reports/gastric-cancer-diagnostic-procedure-market
Rising Awareness of Gastric Cancer Would Provide Growth Opportunities to Global Gastric Cancer Diagnostic Procedure Market Players in Coming Years:
No Stomach For Cancer (NSFC), a nonprofit organization, contributes to spreading awareness and educating people about stomach cancer. The organization supports research focused on screening, early detection, treatment, and prevention of stomach cancer. In November 2010, the NSFC successfully championed and celebrated the first official Stomach Cancer Awareness Month in the US, which became a global event for the awareness of gastric cancer. Since then, November is observed as the Stomach Cancer Awareness Month every year across the globe. The primary goal of the awareness program is to educate people about stomach cancer, shedding light on its risk factors, prevention, and early detection. The NFCS makes financial investments in stomach cancer research for better diagnosis and treatments, improved survival rates, and the ultimate cure.
China has launched National Key Public Health Projects, providing free endoscopic screenings for upper gastrointestinal cancer in more than 110 high-risk areas. Hope For Stomach Cancer is another nonprofit organization that offers resources to patients, caregivers, and loved ones while promoting early detection and prevention in general and medical communities. The organization develops and facilitates programs that assist stomach cancer patients to live the best possible life throughout the phases of the disease. Therefore, a rising number of gastric cancer awareness programs are expected to offer lucrative opportunities for the gastric cancer diagnostic procedures market during the forecast period.
The gastric cancer diagnostic procedure market has been analyzed on the basis of North America, Europe, Asia Pacific, the Middle East & Africa, and South & Central America. North America held the largest market share in 2022, while the US leads the market in this region. The market growth in the country is attributed to rising awareness about gastric cancer among the population and the growing prevalence of gastrointestinal diseases. Further, the gastric cancer diagnostic procedure market in Asia Pacific is expected to grow at the highest CAGR during the forecast period. China held the largest share of the market in this region in 2021, and India is expected to exhibit substantial growth in the market during the forecast period. The market growth in India and China is attributed to the increasing incidence of gastric cancer cases, growing awareness about diagnosis, rising geriatric population, and increasing prevalence of H. pylori infection.
Go through further research published by The Insight Partners: (Purchase with 10% Instant Discount):
Liver Cancer Diagnostics Market Forecast to 2028 - COVID-19 Impact and Global Analysis
Brain Cancer Diagnostics Market Forecast to 2028 - COVID-19 Impact and Global Analysis
Precision Cancer Diagnostic Tests Market Forecast to 2028 - COVID-19 Impact and Global Analysis
Skin Cancer Diagnostics Market Size, Share, and COVID-19 Impact Analysis
Breast Cancer Diagnostics Market Forecast to 2028 - Covid-19 Impact and Global Analysis
About Us:
The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We specialize in industries such as Semiconductor and Electronics, Aerospace and Defense, Automotive and Transportation, Biotechnology, Healthcare IT, Manufacturing and Construction, Medical Device, Technology, Media and Telecommunications, Chemicals and Materials.
Contact Us:
If you have any queries about this report or if you would like further information, please contact us:
Contact Person: Sameer Joshi
E-mail: sales@theinsightpartners.com
Phone: +1-646-491-9876
Press Release: https://www.theinsightpartners.com/pr/gastric-cancer-diagnostic-procedure-market